There’s no basis for that number.
Yes, PFS is uncommon. As I’ve discussed elsewhere:
Recent FAERS and EU data shows the number of adverse events reported is still extremely low compared to the wide use of this drug. However, there’s reason to believe that this condition occurs through a number of anti-androgenic substances, so the patient group suffering a degree of “PFS” is likely considerably larger. It is still, however, a very niche problem, and we need to do all we can to stick together, remain engaged and support further investigative efforts into our issue so that it is eventually considered for what it is: a novel biological mechanism that’s likely to have significant implications in the pathogenesis of other disease states. The fact that most doctors don’t believe the development of PFS (Ie worsening or even starting completely off the drug in many cases) is even possible shows there’s clearly something novel here, and this unusual situation is shared by the other post drug conditions. Something we’re focused on at the moment is making sure the other patient groups experiencing what is essentially the same syndrome (accutane, lupron, anti-depressants etc) are welcomed here and can engage with future organisation and projects.
Regarding the foundation, the establishment of a charity does not mean that limitless funding just appears, and we are hoping to encourage donations through projects we’re launching in the not so distant future.